For inquiries on this matter, please contact
- Mitsui & Co., Ltd.
Corporate Communications Division - Contact form
Main Contents
Mitsui & Co., Ltd. (Mitsui) and Ceva Santé Animale SA (Ceva) today announce the creation of Ceva Bussan Animal Health (Ceva Bussan), a new joint venture that brings together Bussan Animal Health (BAH) and Ceva Japan. As part of the transaction, Mitsui has transferred 60% of its shareholding in BAH to Ceva. Mitsui and Ceva work together as strategic partners to drive growth in the Japanese animal health market.
In parallel, Mitsui has made an additional equity investment in Ceva, further reinforcing the long-standing partnership between Mitsui and Ceva.
Strengthening the strategic collaboration between Mitsui and Ceva
Mitsui and Ceva have built a long-standing strategic partnership in the animal health sector, combining Mitsui's extensive global reach and diverse business portfolio with Ceva's global expertise as the world's fifth-largest animal health company by sales.
This enhanced partnership is intended to accelerate collaboration across broader global initiatives, including the creation of new products and technologies, market expansion and the creation of long-term sustainable value in the animal health industry.
Ceva Bussan represents a cornerstone of this reinforced collaboration, providing an operational platform in Japan.
Ceva Bussan: A strengthened platform to support growth in the Japanese market
Ceva Bussan will offer a broader and more comprehensive product portfolio in the Japanese market by combining BAH's 75-year heritage, expertise and brand strength in the Japanese animal health market, together with its nationwide technical sales organization covering veterinary clinics across Japan, with Ceva's long-established animal health business platform as a leading global animal health company, as well as access to its key livestock and companion animal products and new and next-generation pipelines.
Through this initiative, Mitsui will strengthen its animal health business platform in Japan and pursue the introduction of overseas products, as well as the global expansion of domestically developed products and intellectual property. By creating synergies between these efforts and Mitsui's broad portfolio of business assets—including animal nutrition—and its extensive global network, Mitsui aims to contribute to the sustainable development of the global animal health industry.
Company Profile
| Official name | Ceva Santé Animale SA |
|---|---|
| Head Office Location | Libourne, France |
| Established | 1999 |
| Representative | Marc Prikazsky |
| Revenue | €1.92 billion (2025) |
| Business Activities | Research, development, manufacturing and sales of veterinary pharmaceuticals |
| Website |
Ceva global headquarters
Mitsui’s Materiality
“Build brighter futures, everywhere” as our corporate mission, and to gain the trust and expectations of our stakeholders to realize a better tomorrow for earth and for people around the world, we have identified six material issues (“Materiality”) for Mitsui’s sustainable growth. We anticipate this particular project/ business to contribute especially to the realization of “Establish a foundation for sustainable and stable supply” and “Foster a well-being society”
-
Establish a foundation for sustainable and stable supply
-
Create a community coexisting with nature
-
Foster a well-being society
-
Cultivate societies that respect human rights
-
Empower our people to build brighter futures
-
Build an organization with integrity
